NasdaqGS - Nasdaq Real Time Price • USD
Solid Biosciences Inc. (SLDB)
At close: April 25 at 4:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 6,234,767 | 15 |
| Sales | 35,077 | 8 |
| Net Shares Purchased (Sold) | 6,199,690 | 23 |
| Total Insider Shares Held | 297.52k | -- |
| % Net Shares Purchased (Sold) | -105.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SMITH IAN F Director | -- | Direct | -- | Apr 3, 2024 |
| GANOT ILAN Director | Sale at price 7.99 per share. | Indirect | 1,111 | Jan 29, 2024 |
| GANOT ILAN Director | -- | Indirect | -- | Jan 26, 2024 |
| KOPPEL ADAM M Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 7.70 per share. | Indirect | 6,962,032 | Jan 11, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 7.70 per share. | Indirect | 6,962,032 | Jan 11, 2024 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.70 per share. | Indirect | 26,262,490 | Jan 11, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.70 per share. | Indirect | 6,962,032 | Jan 11, 2024 |
| TAN KEVIN Chief Financial Officer | Sale at price 8.20 per share. | Direct | 32,267 | Jan 9, 2024 |
| TAN KEVIN Chief Financial Officer | -- | Direct | -- | Jan 9, 2024 |
| SMITH IAN F Director | -- | Direct | -- | Jan 3, 2024 |
| GANOT ILAN Director | Sale at price 5.30 per share. | Indirect | 6,052 | Jan 3, 2024 |
| GANOT ILAN Director | -- | Indirect | -- | Jan 3, 2024 |
| HOWTON DAVID TYRONNE Chief Operating Officer | Sale at price 2.78 per share. | Direct | 14,920 | Dec 4, 2023 |
| CUMBO ALEXANDER Chief Executive Officer | Sale at price 2.77 per share. | Direct | 32,516 | Dec 4, 2023 |
| MARLOWE JENNIFER Officer | Sale at price 2.77 per share. | Direct | 13,525 | Dec 4, 2023 |
| HANRAHAN JESSIE Officer | Sale at price 2.78 per share. | Direct | 13,562 | Dec 4, 2023 |
| HERZICH PAUL Chief Technology Officer | Sale at price 2.77 per share. | Direct | 8,232 | Dec 4, 2023 |
| HOWTON DAVID TYRONNE Chief Operating Officer | -- | Direct | -- | Dec 1, 2023 |
| CUMBO ALEXANDER Chief Executive Officer | -- | Direct | -- | Dec 1, 2023 |
| GANOT ILAN Director | -- | Direct | -- | Dec 1, 2023 |
| MARLOWE JENNIFER Officer | -- | Direct | -- | Dec 1, 2023 |
| HANRAHAN JESSIE Officer | -- | Direct | -- | Dec 1, 2023 |
| HERZICH PAUL Chief Technology Officer | -- | Direct | -- | Dec 1, 2023 |
| SMITH IAN F Director | -- | Direct | -- | Oct 3, 2023 |
| GANOT ILAN Director | -- | Direct | -- | Sep 1, 2023 |
| SMITH IAN F Director | -- | Direct | -- | Jul 3, 2023 |
| GANOT ILAN Director | -- | Indirect | -- | Jun 2, 2023 |
| GANOT ILAN Director | Sale at price 4.85 per share. | Indirect | 2,364 | May 2, 2023 |
| SMITH IAN F Director | -- | Direct | -- | Apr 3, 2023 |
| GANOT ILAN Director | -- | Direct | -- | Mar 2, 2023 |
| GANOT ILAN Director | Sale at price 7.49 per share. | Indirect | 11,407 | Jan 27, 2023 |
| GANOT ILAN Director | -- | Indirect | -- | Jan 27, 2023 |
| MORRIS CARL ASHLEY Officer | Sale at price 7.49 per share. | Direct | 3,303 | Jan 27, 2023 |
| MORRIS CARL ASHLEY Officer | -- | Direct | -- | Jan 27, 2023 |
| SMITH IAN F Director | -- | Direct | -- | Jan 3, 2023 |
| SMITH IAN F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 2, 2022 |
| CUMBO ALEXANDER Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 2, 2022 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 - 7.05 per share. | Indirect | 15,249,996 | Dec 2, 2022 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 - 7.05 per share. | Indirect | 15,249,996 | Dec 2, 2022 |
| SMITH IAN F Director | -- | Direct | -- | Oct 3, 2022 |
| SMITH IAN F Director | -- | Direct | -- | Jul 1, 2022 |
| SMITH IAN F Director | -- | Direct | -- | Apr 1, 2022 |
| MORRIS CARL ASHLEY Officer | Sale at price 1.10 per share. | Direct | 24,932 | Mar 14, 2022 |
| SCHNEIDER JOEL SOLOMON ZEV Chief Operating Officer | Sale at price 1.10 per share. | Direct | 33,554 | Mar 14, 2022 |
| GANOT ILAN Chief Executive Officer | Sale at price 1.12 per share. | Indirect | 519 | Feb 10, 2022 |
| KOPPEL ADAM M Director | Stock Award(Grant) at price 5.75 per share. | Indirect | 4,999,999 | Mar 23, 2021 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.75 per share. | Indirect | 14,999,996 | Mar 23, 2021 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.75 per share. | Indirect | 12,688,439 | Mar 19, 2021 |
| MORRIS CARL ASHLEY Officer | Sale at price 8.84 - 8.85 per share. | Direct | 206,947 | Mar 12, 2021 |
| SCHNEIDER JOEL SOLOMON ZEV Chief Operating Officer | Sale at price 8.84 per share. | Direct | 206,920 | Mar 12, 2021 |
Related Tickers
VYGR Voyager Therapeutics, Inc.
7.42
-1.98%
APRE Aprea Therapeutics, Inc.
5.35
+5.52%
DTIL Precision BioSciences, Inc.
9.72
-1.02%
ATXS Astria Therapeutics, Inc.
9.17
+1.89%
RGNX REGENXBIO Inc.
16.06
+0.12%
PTCT PTC Therapeutics, Inc.
25.49
+1.11%
SLRN Acelyrin, Inc.
4.2400
-7.22%
ADCT ADC Therapeutics SA
4.4400
-7.11%
APLT Applied Therapeutics, Inc.
4.2300
-1.86%
DNTH Dianthus Therapeutics, Inc.
20.99
-1.55%